Akoya Biosciences, Inc.
AKYA
$1.16
$0.021.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 27.54M | 35.04M | 35.90M | 45.22M | 61.58M |
| Total Receivables | 11.74M | 13.78M | 12.79M | 16.55M | 13.47M |
| Inventory | 22.85M | 24.32M | 25.21M | 24.80M | 22.99M |
| Prepaid Expenses | 4.07M | 3.26M | 2.97M | 2.94M | 3.79M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 331.00K | -- | -- | -- |
| Total Current Assets | 66.21M | 76.73M | 76.86M | 89.51M | 101.83M |
|
|
|||||
| Total Current Assets | 66.21M | 76.73M | 76.86M | 89.51M | 101.83M |
| Net Property, Plant & Equipment | 12.09M | 12.98M | 13.97M | 14.47M | 15.88M |
| Long-term Investments | 18.26M | 18.26M | 18.26M | 18.26M | 18.26M |
| Goodwill | 18.26M | 18.26M | 18.26M | 18.26M | 18.26M |
| Total Other Intangibles | 13.85M | 14.56M | 15.27M | 15.99M | 16.70M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.24M | 2.47M | 2.21M | 2.02M | 2.08M |
| Total Assets | 112.65M | 125.01M | 129.97M | 143.75M | 154.75M |
|
|
|||||
| Total Accounts Payable | 10.29M | 8.76M | 8.76M | 9.79M | 10.75M |
| Total Accrued Expenses | 8.58M | 8.50M | 6.77M | 10.45M | 7.14M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 79.70M | 3.28M | 3.68M | 3.32M | 3.37M |
| Total Finance Division Other Current Liabilities | 9.51M | 8.90M | 8.79M | 9.18M | 11.93M |
| Total Other Current Liabilities | 9.51M | 8.90M | 8.79M | 9.18M | 11.93M |
| Total Current Liabilities | 108.08M | 29.44M | 27.99M | 32.74M | 33.19M |
|
|
|||||
| Total Current Liabilities | 108.08M | 29.44M | 27.99M | 32.74M | 33.19M |
| Long-Term Debt | -- | 76.18M | 75.90M | 75.68M | 75.47M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.02M | 4.68M | 5.34M | 5.69M | 6.35M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.43M | 7.10M | 7.11M | 7.38M | 7.02M |
| Total Liabilities | 118.54M | 117.41M | 116.34M | 121.50M | 122.03M |
|
|
|||||
| Common Stock & APIC | 295.20M | 293.02M | 290.86M | 288.97M | 286.29M |
| Retained Earnings | -301.09M | -285.44M | -277.24M | -266.70M | -253.56M |
| Treasury Stock & Other | -1.00K | 7.00K | 8.00K | -12.00K | -16.00K |
| Total Common Equity | -5.89M | 7.60M | 13.63M | 22.25M | 32.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.89M | 7.60M | 13.63M | 22.25M | 32.72M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.89M | 7.60M | 13.63M | 22.25M | 32.72M |
|
|
|||||